Suppr超能文献

溶剂同位素效应对胃蛋白酶抑制剂抑制猪胃蛋白酶起始作用的影响。

Solvent isotope effects on the onset of inhibition of porcine pepsin by pepstatin.

作者信息

Cho Y K, Rebholz K L, Northrop D B

机构信息

Division of Pharmaceutical Biochemistry, School of Pharmacy, University of Wisconsin, Madison 53706.

出版信息

Biochemistry. 1994 Aug 16;33(32):9637-42. doi: 10.1021/bi00198a032.

Abstract

Pepstatin is a slow and tight-binding inhibitor of pepsin. Preincubating enzyme and inhibitor in H2O and in D2O in the absence of substrate generates an inverse solvent isotope effect of Dk = 0.69 +/- 0.06 on the apparent first-order rate constant for the decay in enzymatic activity. Proton inventory analysis of the inverse isotope effect suggests a single transition-state proton with a fractionation factor of 1.41 +/- 0.05. In contrast, combining enzyme with inhibitor and substrate (Leu-Ser-p-nitro-Phe-Nle-Ala-Leu-OMe) simultaneously along with observing the decay in enzymatic activity during catalytic turnovers generates a normal solvent isotope effect of Dk = 1.25 +/- 0.09. Proton inventory analysis of the normal isotope effect suggests a single reactant-state proton with a fractionation factor of 1.46 +/- 0.03. These two experimental designs are often considered equivalent, but the differences in isotopic data require that the pathway for onset of pepstatin inhibition in the absence of substrate must be different from the pathway in the presence of substrate. In the former, the inhibitor can only bind to free enzyme; in the latter, the inhibitor is hindered from binding to free enzyme because of competition with substrate but can bind to intermediate forms of enzyme generated during catalytic turnovers, downstream from enzyme-product complexes.

摘要

胃蛋白酶抑制剂是一种作用缓慢且结合紧密的胃蛋白酶抑制剂。在无底物的情况下,将酶和抑制剂在H₂O和D₂O中预孵育,会对酶活性衰减的表观一级速率常数产生Dk = 0.69 ± 0.06的反向溶剂同位素效应。对反向同位素效应进行质子库存分析表明,存在一个单一的过渡态质子,其分馏系数为1.41 ± 0.05。相比之下,将酶与抑制剂和底物(亮氨酸 - 丝氨酸 - 对硝基苯丙氨酸 - 正亮氨酸 - 丙氨酸 - 亮氨酸 - 甲酯)同时混合,并在催化周转过程中观察酶活性的衰减,则会产生Dk = 1.25 ± 0.09的正常溶剂同位素效应。对正常同位素效应进行质子库存分析表明,存在一个单一的反应物态质子,其分馏系数为1.46 ± 0.03。这两种实验设计通常被认为是等效的,但同位素数据的差异表明,在无底物时胃蛋白酶抑制剂抑制作用的起始途径必定与有底物时的途径不同。在前者中,抑制剂只能与游离酶结合;在后者中,由于与底物竞争,抑制剂无法与游离酶结合,但可以与催化周转过程中产生的酶的中间形式结合,这些中间形式位于酶 - 产物复合物下游。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验